Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation
- PMID: 1720738
- DOI: 10.1007/BF00265905
Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation
Abstract
Transcutaneous oxygen pressure (tcPo2), laser Doppler flux and capillary microscopy have been used to examine the forefoot skin in 5 healthy men and 8 patients with severe peripheral arterial occlusive disease in order to evaluate the dose dependent effects of iloprost on skin microcirculation. Iloprost was infused IV starting at 0.0625 ng.kg-1.min-1 and doubling the dose every 15 min up to 2 ng.kg-1.min-1. While tcPo2 at an electrode core temperature of 44 degrees C decreased in both patients and controls, there was a significant dose dependent increase in tcPo2 (37 degrees C) in the controls from 0.25 ng.kg-1.min-1. In the patients the reaction was variable: it was decreased in two and increased in 6, with a maximum either at 0.25-0.5 ng.kg-1.min-1 (n = 3) or at the highest dose (1.0 or 2.0 ng.kg-1.min-1; n = 3). Mean laser Doppler flux in both groups was increased, although the reaction was not consistent in the patients. Density of forefoot skin capillaries was reduced in 3 patients, and in the others the flow velocity was very low. During infusion of iloprost, both an increase in capillary density and blood cell velocity were observed. The effects were of variable intensity and occurred at varying doses, some appeared early and diminished as the dose was increased, and others were found only at 2 ng.kg-1.min-1. Adverse effects were numerous, extending from harmless skin flushing to mental changes and a quickly reversible attack of angina pectoris.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.Angiology. 1995 May;46(5):357-67. doi: 10.1177/000331979504600501. Angiology. 1995. PMID: 7741319
-
Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.Vasa. 1998 May;27(2):100-5. Vasa. 1998. PMID: 9612114
-
[Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease--is quantification of the therapeutic effect possible with tcPO2 measurements?].Vasa. 1995;24(1):62-71. Vasa. 1995. PMID: 7536999 Clinical Trial. German.
-
Microvascular changes in arterial occlusive disease: target for pharmacotherapy.Vasc Med. 1996;1(1):50-4. doi: 10.1177/1358863X9600100109. Vasc Med. 1996. PMID: 9546915 Review.
-
[The status of laser Doppler examination in patients with arterial occlusive disease].Herz. 1988 Dec;13(6):382-91. Herz. 1988. PMID: 3061920 Review. German.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous